- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07923864
An Efficacy Trial of The Toolkit for Optimal Recovery After Concussion
The goal of this study is to test the efficacy of the Toolkit for Optimal Recovery after Concussion (TOR-C), a brief live-video mind-body program. aiming to prevent chronic concussion symptoms and optimize recovery.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Mass General Brigham
-
Kontakt:
- Jonathan Greenberg
- Telefonnummer: 617-643-9402
- E-mail: MGHConcusionToolkit@partners.org
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Sustained a concussion 3-10 weeks earlier
- At least mild anxiety symptoms (score ≥ 5 on GAD-7 anxiety scale)
- Age 18-35
- English fluency and literacy
- Ability and willingness to participate in study procedures, assessments, and intervention
- Access to a smartphone or computer with internet access
- Cleared for participation by clinic/study staff
Exclusion Criteria:
- Participation in mind-body or CBT treatment in the past 3 months
- Concussion in the past 2 years that resulted in symptoms lasting 3 months or more / current or previous complicated or moderate/severe TBI
- Practice of mindfulness techniques > 45 minutes/week in the past 3 months
- Change in psychotropic medications (e.g., antidepressant, anxiolytics) in the past 6 weeks
- Uncontrolled bipolar disorder, psychosis, active substance dependence, self reported current active suicidal ideation with plan and/or intent
- Pregnancy
- Serious comorbidity expected to worsen in the next 6 months
- Secondary gains that may bias motivation (e.g., pending disability claim)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Toolkit for Optimal Recovery after Concussion (TOR-C)
A 4-week mind-body program delivered via live video (Zoom) 1:1 with a clinician delivering mind-body and cognitive-behavioral skills. |
TOR-C is a brief behavioral mind-body program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It targets anxiety and fear-avoidance factors to prevent chronic concussion symptoms, combining mind-body skills (e.g., mindfulness, deep breathing, acceptance), light cognitive-behavioral skills, skills for gradual return to activity, and concussion psychoeducation. |
|
Aktiv komparator: Health Enhancement after Concussion (HE-C)
A 4-week program delivered via live video (Zoom) 1:1 with a clinician delivering psychoeducation and information about healthy living after a concussion |
HE-C is an attention-matched active control program delivered remotely via live video over four weekly 45-minute sessions, with approximately 10 minutes of daily home practice. It provides general health education after concussion (e.g., sleep, nutrition, physical activity) without the specific skills included in TOR-C. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Post-Concussion Symptom Scale (PCSS)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures the severity of concussion symptoms (e.g., headache, fatigue, dizziness, difficulty concentrating). This is the study's primary outcome; efficacy is judged mainly on reducing these symptoms. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Generalized Anxiety Disorder scale (GAD-7)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures the severity of anxiety symptoms. (Also used at screening, where a score ≥5 is required for eligibility.) |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Patient Health Questionnaire-9 (PHQ-9)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures the severity of depression symptoms. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Fear Avoidance Behavior after Traumatic Brain Injury (FAB-TBI)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures fear-avoidance behavior, i.e., avoiding activities out of fear they will worsen symptoms. A core mechanism in the fear-avoidance model. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Symptom Catastrophizing Scale
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures the tendency to catastrophize concussion symptoms (magnifying, ruminating on, or feeling helpless about them). |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures mindfulness, i.e., present-moment awareness and acceptance of thoughts and feelings. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Behavioral Response to Illness Questionnaire (BRIQ): Limiting behavior subscale
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Measures the tendency to limit or avoid various activities in response to medical conditions |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
An exploratory outcome which measures sleep quality over the past month. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
PROMIS Cognitive Function
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
An exploratory outcome which measures self-reported cognitive function (e.g., perceived problems with memory, attention, and thinking). |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
|
WHO Disability Assessment Schedule (WHODAS 2.0; 12-item version)
Tidsramme: Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
It is 12-item measure of health-related functioning and disability across daily activities (e.g., cognition, mobility, self-care, social participation) over the past 30 days, with higher scores indicating greater disability. |
Baseline (week 0), post-test (week 4), 6-month follow-up (week 28)
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Greenberg J, Singh T, Iverson GL, Silverberg ND, Macklin EA, Parker RA, Giacino JT, Yeh GY, Vranceanu AM. A Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2021 Jan 14;10(1):e25746. doi: 10.2196/25746.
- Greenberg J, Levey NS, Becker M, Yeh GY, Giacino JT, Iverson G, Silverberg ND, Parker RA, Vranceanu AM. Feasibility Randomized Controlled Trial of the Toolkit for Optimal Recovery After Concussion: A Live Video Program to Prevent Persistent Concussion Symptoms in Young Adults With Anxiety. Arch Phys Med Rehabil. 2025 Apr;106(4):527-536. doi: 10.1016/j.apmr.2024.10.011. Epub 2024 Nov 5.
- Becker ME, Stratton Levey N, Yeh GY, Giacino J, Iverson G, Silverberg N, Parker RA, McKinnon E, Siravo C, Shah P, Vranceanu AM, Greenberg J. Preliminary Feasibility of a Novel Mind-Body Program to Prevent Persistent Concussion Symptoms Among Young Adults With Anxiety: Nonrandomized Open Pilot Study. JMIR Form Res. 2024 Nov 8;8:e64540. doi: 10.2196/64540.
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Hjerneskader, traumatiske
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Psykiske lidelser
- Sår og skader
- Patologiske processer
- Kraniocerebralt traume
- Traumer, nervesystemet
- Hovedskader, Lukket
- Sår, ikke-gennemtrængende
- Hjerneskader
- Patologiske tilstande, tegn og symptomer
- Angstlidelser
- Sygdom
- Hjernerystelse
- Post-hjernerystelse syndrom
Andre undersøgelses-id-numre
- 1R01AT014198-01
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
We plan to share our study protocol, analysis plan, data dictionary, and de-identified data from all measures described under "outcome measures"
IPD-delingstidsramme
Data from this study will be deposited into the Vivli database no later than one year of the completion of the funded project period
IPD-delingsadgangskriterier
Interested parties can create an account in the Vivli Database and submit a request to access study data
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .